311
Views
43
CrossRef citations to date
0
Altmetric
Perspective

Indications and safety of intravenous and subcutaneous immunoglobulin therapy

, , &
Pages 301-316 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Farzaneh Rahmani, Asghar Aghamohammadi, Hans D. Ochs & Nima Rezaei. (2017) Agammaglobulinemia: comorbidities and long-term therapeutic risks. Expert Opinion on Orphan Drugs 5:7, pages 559-574.
Read now
Bahar Ataeinia, Ali Montazeri, Marzieh Tavakol, Gholamreza Azizi, Fatemeh Kiaee, Naiimeh Tavakolinia, Babak Negahdari, Javad Mohammadi, Hassan Abolhassani, Nima Rezaei & Asghar Aghamohammadi. (2017) Measurement of Health-Related Quality of Life in Primary Antibody-Deficient Patients. Immunological Investigations 46:4, pages 329-340.
Read now
Hosein Shabaninejad, Asra Asgharzadeh, Nima Rezaei & Aziz Rezapoor. (2016) A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis. Expert Review of Clinical Immunology 12:5, pages 595-602.
Read now
Gholamreza Azizi, Hassan Abolhassani, Mohammad hossein Asgardoon, Shiva Shaghaghi, Babak Negahdari, Javad Mohammadi, Nima Rezaei & Asghar Aghamohammadi. (2016) Managing patients with side effects and adverse events to immunoglobulin therapy. Expert Review of Clinical Pharmacology 9:1, pages 91-102.
Read now
Hasssan Abolhassani, Mohammad Hossein Asgardoon, Nima Rezaei, Lennart Hammarstrom & Asghar Aghamohammadi. (2015) Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?. Expert Review of Clinical Immunology 11:11, pages 1229-1243.
Read now
Bamdad Sadeghi, Hassan Abolhassani, Ali Naseri, Nima Rezaei & Asghar Aghamohammadi. (2015) Economic burden of common variable immunodeficiency: annual cost of disease. Expert Review of Clinical Immunology 11:5, pages 681-688.
Read now
Maryam Ebadi, Asghar Aghamohammadi & Nima Rezaei. (2015) Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics. Expert Review of Clinical Immunology 11:1, pages 117-139.
Read now
Asghar Aghamohammadi, Hassan Abolhassani, AmirHossein Latif, Firouzeh Tabassomi, Tahaamin Shokuhfar, Babak Torabi Sagvand, Shervin Shahinpour, Babak Mirminachi, Nima Parvaneh, Masoud Movahedi, Mohammad Gharagozlou, Roya Sherkat, Reza Amin, Soheila Aleyasin, Reza Faridhosseini, Farahzad Jabbari-Azad, Taher Cheraghi, Mohamad Hosein Eslamian, Abbas Khalili, Najmoddin Kalantari, Alireza Shafiei, Abbas Dabbaghzade, Alireza Khayatzadeh, Mohsen Ebrahimi, Davood Razavinejad, Saeid Bazregari, Mehran Ebrahimi, Javad Ghaffari, Mohammad Hassan Bemanian, Nasrin Behniafard, Sara Kashef, Iraj Mohammadzadeh, Lennart Hammarström & Nima Rezaei. (2014) Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients. Expert Review of Clinical Immunology 10:10, pages 1405-1417.
Read now
Hassan Abolhassani, Babak Torabi Sagvand, Tahaamin Shokuhfar, Babak Mirminachi, Nima Rezaei & Asghar Aghamohammadi. (2013) A review on guidelines for management and treatment of common variable immunodeficiency. Expert Review of Clinical Immunology 9:6, pages 561-575.
Read now
Elena S Resnick & Charlotte Cunningham-Rundles. (2013) Treatment of common variable immune deficiency. Expert Opinion on Orphan Drugs 1:2, pages 157-166.
Read now
John B Hagan, Richard L Wasserman, Jeffrey S Baggish, Martin O Spycher, Melvin Berger, Vandana Shashi, Emanuel Lohrmann & Kathleen E Sullivan. (2012) Safety of L-proline as a stabilizer for immunoglobulin products. Expert Review of Clinical Immunology 8:2, pages 169-178.
Read now

Articles from other publishers (32)

Safa Baris, Hassan Abolhassani, Michel J. Massaad, Maryam Al-Nesf, Zahra Chavoshzadeh, Sevgi Keles, Ismail Reisli, Azzeddine Tahiat, Hiba Mohammad Shendi, Dalia Abd Elaziz, Brahim Belaid, Fatima Al Dhaheri, Sule Haskologlu, Figen Dogu, Imen Ben-Mustapha, Ali Sobh, Nermeen Galal, Safa Meshaal, Rabab Elhawary, Aisha El-marsafy, Fayhan J. Alroqi, Bandar Al-Saud, Mona Al-Ahmad, Tariq Al Farsi, Nashat AL Sukaiti, Salem Al-Tamemi, Cybel Mehawej, Ghassan Dbaibo, Gehad ElGhazali, Sara Sebnem Kilic, Ferah Genel, Ayca Kiykim, Ugur Musabak, Hasibe Artac, Sukru Nail Guner, Rachida Boukari, Reda Djidjik, Nadia Kechout, Deniz Cagdas, Zeinab Awad El-Sayed, Elif Karakoc-Aydiner, Raed Alzyoud, Mohamed Ridha Barbouche, Mehdi Adeli, Rima Hanna Wakim, Shereen M. Reda, Aydan Ikinciogullari, Ahmet Ozen, Aziz Bousfiha, Hamoud Al-Mousa, Nima Rezaei, Waleed Al-Herz & Raif S. Geha. (2023) The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity. The Journal of Allergy and Clinical Immunology: In Practice 11:1, pages 158-180.e11.
Crossref
Ilse R. Dubbelboer & Erik Sjögren. (2022) Overview of authorized drug products for subcutaneous administration: Pharmaceutical, therapeutic, and physicochemical properties. European Journal of Pharmaceutical Sciences 173, pages 106181.
Crossref
Jia-Chen Li, Jing Zhao, Hao Li, Li-Qun Fang & Wei Liu. (2022) Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome. Infectious Medicine 1:1, pages 40-49.
Crossref
Zahra Kolahchi, Hanye Sohrabi, Sara Ekrami Nasab, Hesan Jelodari Mamaghani, Maryam Keyfari Alamdari & Nima Rezaei. (2021) Potential therapeutic approach of intravenous immunoglobulin against COVID-19. Allergy, Asthma & Clinical Immunology 17:1.
Crossref
Hossein Esmaeilzadeh, Aida Askarisarvestani, Nazanin Hosseini, Sahar Samimi, Alireza Shafiei, Seyed Alireza Mahdaviani, Narges Eslami, Zahra Chavoshzadeh, Mazdak Fallahi, Nasrin Khakbazanfard, Mahnaz Sadeghi Shabestari, Soheila Aleyasin, Seyed Hesamedin Nabavizadeh, Taher Cheraghi, Arash Kalantari, Akefeh Ahmadiafshar, Mojgan Safari, Mohammad Hossein Eslamian, Rasol Molatefi, Afshin Shirkani, Marzieh Heidarzadeh Arani, Marzieh Tavakol, Mohammad Hassan Bemanian, Saba Arshi, Mohammad Nabavi, Sima Shokri, Babak Shahhosseini, Negar Mortazavi, Pooria Nakhaei, Farzad Nazari, Morteza Fallahpour, Hamid Ahanchian, Nasrin Moazzen, Maryam Khoshkhui, Ahmad Vosughi Motlagh, Asghar Aghamohammadi, Hassan Abolhassani, Reza Yazdani & Nima Rezaei. (2021) Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin. Clinical Immunology 230, pages 108826.
Crossref
Fateme Babaha & Nima Rezaei. (2020) Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?. The American Journal of the Medical Sciences 360:6, pages 740-741.
Crossref
Béatrice Ramus, Omar Benbrahim & Patrick Chérin. (2019) Utilisation des immunoglobulines humaines intraveineuses et sous-cutanées. Soins 64:833, pages 13-18.
Crossref
Reza Yazdani, Saba Fekrvand, Sepideh Shahkarami, Gholamreza Azizi, Bobak Moazzami, Hassan Abolhassani & Asghar Aghamohammadi. (2019) The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clinical Immunology 198, pages 19-30.
Crossref
Chiara Azzari & Clementina Canessa. 2019. Humoral Primary Immunodeficiencies. Humoral Primary Immunodeficiencies 253 274 .
Masato Takeuchi, Shuichi Ito, Masaki Nakamura & Koji Kawakami. (2018) Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan. Pediatric Drugs 20:6, pages 585-591.
Crossref
David Yang-Wei Fann, Yun-An Lim, Yi-Lin Cheng, Ker-Zhing Lok, Prasad Chunduri, Sang-Ha Baik, Grant R. Drummond, S. Thameem Dheen, Christopher G. Sobey, Dong-Gyu Jo, Christopher Li-Hsian Chen & Thiruma V. Arumugam. (2017) Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke. Molecular Neurobiology 55:2, pages 1082-1096.
Crossref
A. Tak Manesh, G. Azizi, A. Heydari, F. Kiaee, M. Shaghaghi, N. Hossein-Khannazer, R. Yazdani, H. Abolhassani & A. Aghamohammadi. (2017) Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?. Allergologia et Immunopathologia 45:6, pages 602-615.
Crossref
Hosein Shabaninejad, Asra Asgharzadeh, Nima Rezaei & Aziz Rezapour. (2017) Estimating the Cost of Immunoglobulin Replacement Therapy in Primary Immunodeficiency Patients. Iranian Journal of Pediatrics 27:4.
Crossref
I. Marie, P. Chérin, M. Michallet, E. Pelus, J. Dantal, J.-C. Crave, J.-C. Delain & J.-F. Viallard. (2017) Prise en charge des événements indésirables chez les patients sous traitement par immunoglobulines : recommandations pour la pratique clinique. La Revue de Médecine Interne 38:5, pages 312-319.
Crossref
Asghar Aghamohammadi, Alessandro Plebani, Vassilios Lougaris, Anne Durandy, Antonio Condino-Neto, Hirokazu Kanegane & Lennart Hammarström. 2017. Primary Immunodeficiency Diseases. Primary Immunodeficiency Diseases 183 244 .
Quentin Scanvion, Guillaume Lefèvre, Eric Hachulla, Pierre-Yves Hatron & Marc Lambert. (2016) Subcutaneous Immunoglobulin Therapy Prevents Systemic Capillary Leak Syndrome Attack. The American Journal of Medicine 129:7, pages e77-e78.
Crossref
B. Torabi Sagvand, B. Mirminachi, H. Abolhassani, T. Shokouhfar, T. Keihanian, A. Amirzargar, A. Mahdaviani & A. Aghamohammadi. (2015) IgG anti-IgA antibodies in paediatric antibody-deficient patients receiving intravenous immunoglobulin. Allergologia et Immunopathologia 43:4, pages 403-408.
Crossref
Misa Hirose, Benjamin Tiburzy, Norito Ishii, Elena Pipi, Sabina Wende, Ellen Rentz, Falk Nimmerjahn, Detlef Zillikens, Rudolf A. Manz, Ralf J. Ludwig & Michael Kasperkiewicz. (2015) Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology 135:3, pages 768-775.
Crossref
H. Abolhassani, A. Hirbod-Mobarakeh, S. Shahinpour, M. Panahi, P. Mohammadinejad, B. Mirminachi, M.S. Shakari, B. Samavat & A. Aghamohammadi. (2015) Mortality and morbidity in patients with X-linked agammaglobulinaemia. Allergologia et Immunopathologia 43:1, pages 62-66.
Crossref
Asghar Aghamohammadi, Payam Mohammadinejad, Hassan Abolhassani, Babak Mirminachi, Masoud Movahedi, Mohammad Gharagozlou, Nima Parvaneh, Vaheid Zeiaee, Bahram Mirsaeed-Ghazi, Zahra Chavoushzadeh, Alireza Mahdaviani, Mahboubeh Mansouri, Sedigheh Yousefzadegan, Bahareh Sharifi, Fariborz Zandieh, Ehsan Hedayat, Ali Nadjafi, Roya Sherkat, Behzad Shakerian, Mahnaz Sadeghi-Shabestari, Reza Farid Hosseini, Farahzad Jabbari-Azad, Hamid Ahanchian, Fatemeh Behmanesh, Mohammadreza Zandkarimi, Afshin Shirkani, Taher Cheraghi, Abbas Fayezi, Iraj Mohammadzadeh, Reza Amin, Soheila Aleyasin, Mojgan Moghtaderi, Javad Ghaffari, Saba Arshi, Naser Javahertrash, Mohammad Nabavi, Mohammad Hassan Bemanian, Alireza Shafiei, Najmedin Kalantari, Akefeh Ahmadiafshar, Hossein Ali Khazaei, Lida Atarod & Nima Rezaei. (2014) Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry. Journal of Clinical Immunology 34:4, pages 478-490.
Crossref
Ilja Ritamo, Marc Cloutier, Leena Valmu, Sonia Néron & Jarkko Räbinä. (2014) Comparison of the glycosylation of in vitro generated polyclonal human IgG and therapeutic immunoglobulins. Molecular Immunology 57:2, pages 255-262.
Crossref
Bharath Wootla, Aleksandar Denic & Moses Rodriguez. 2014. Human Monoclonal Antibodies. Human Monoclonal Antibodies 79 110 .
Vibhav K. Bansal & Matthew N. Meriggioli. 2014. Neuromuscular Disorders in Clinical Practice. Neuromuscular Disorders in Clinical Practice 341 362 .
R. Goulabchand, F. Batteux & P. Guilpain. (2013) Glycosylation des autoanticorps au cours des maladies auto-immunes. La Revue de Médecine Interne 34:12, pages 746-753.
Crossref
Jenny Lingman-Framme & Anders Fasth. (2013) Subcutaneous Immunoglobulin for Primary and Secondary Immunodeficiencies: an Evidence-Based Review. Drugs 73:12, pages 1307-1319.
Crossref
Levente Bodoki, Melinda Vincze, Zoltán Griger & Katalin Dankó. (2013) Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy. Orvosi Hetilap 154:19, pages 723-728.
Crossref
Ilja Ritamo, Jarkko Räbinä, Suvi Natunen & Leena Valmu. (2013) Nanoscale reversed-phase liquid chromatography–mass spectrometry of permethylated N-glycans. Analytical and Bioanalytical Chemistry 405:8, pages 2469-2480.
Crossref
Hassan Abolhassani, Mohammad Salehi Sadaghiani, Asghar Aghamohammadi, Hans D. Ochs & Nima Rezaei. (2012) Home-Based Subcutaneous Immunoglobulin Versus Hospital-Based Intravenous Immunoglobulin in Treatment of Primary Antibody Deficiencies: Systematic Review and Meta Analysis. Journal of Clinical Immunology 32:6, pages 1180-1192.
Crossref
Jemima Albayda & Lisa Christopher-Stine. (2012) Novel approaches in the treatment of myositis and myopathies. Therapeutic Advances in Musculoskeletal Disease 4:5, pages 369-377.
Crossref
Asghar AghamohammadiHassan AbolhassaniArmin Hirbod-MobarakehFariba GhassemiShervin ShahinpourNasrin BehniafardGhazal NaghibzadehAmir ImanzadehNima Rezaei. (2012) The Uncommon Combination of Common Variable Immunodeficiency, Macrophage Activation Syndrome, and Cytomegalovirus Retinitis. Viral Immunology 25:2, pages 161-165.
Crossref
Christina Lam & Ruth Ann Vleugels. (2012) Management of cutaneous dermatomyositis. Dermatologic Therapy 25:2, pages 112-134.
Crossref
Stephen Jolles, Mark R. Stein, Hilary J. Longhurst, Michael Borte, Bruce Ritchie, Matthias H. Sturzenegger & Melvin Berger. (2011) New Frontiers in Subcutaneous Immunoglobulin Treatment. Biologics in Therapy 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.